GB2013084B - Ophthalmic drug dosage - Google Patents
Ophthalmic drug dosageInfo
- Publication number
- GB2013084B GB2013084B GB7845835A GB7845835A GB2013084B GB 2013084 B GB2013084 B GB 2013084B GB 7845835 A GB7845835 A GB 7845835A GB 7845835 A GB7845835 A GB 7845835A GB 2013084 B GB2013084 B GB 2013084B
- Authority
- GB
- United Kingdom
- Prior art keywords
- drug dosage
- ophthalmic drug
- ophthalmic
- dosage
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87207478A | 1978-01-25 | 1978-01-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2013084A GB2013084A (en) | 1979-08-08 |
GB2013084B true GB2013084B (en) | 1982-07-28 |
Family
ID=25358780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7845835A Expired GB2013084B (en) | 1978-01-25 | 1978-11-23 | Ophthalmic drug dosage |
Country Status (7)
Country | Link |
---|---|
JP (2) | JPS6059885B2 (fr) |
CA (1) | CA1108053A (fr) |
CH (1) | CH640737A5 (fr) |
DE (1) | DE2902863C2 (fr) |
FR (1) | FR2415459A1 (fr) |
GB (1) | GB2013084B (fr) |
MX (1) | MX6520E (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4347238A (en) | 1979-10-26 | 1982-08-31 | Smith & Nephew Associated Companies Limited | Autoclavable emulsion containing silver sulphadiazine |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2075837B (en) * | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
US6255299B1 (en) | 1985-01-07 | 2001-07-03 | Leo Pharmaceutical Products Ltd. | Opthalmic gel composition and method of treating eye infections |
GB8500310D0 (en) * | 1985-01-07 | 1985-02-13 | Leo Pharm Prod Ltd | Pharmaceutical preparation |
US5192535A (en) * | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
US5188826A (en) * | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
JP2873530B2 (ja) * | 1991-12-13 | 1999-03-24 | 参天製薬株式会社 | ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤 |
CN1049358C (zh) * | 1993-01-01 | 2000-02-16 | 参天制药株式会社 | 含羧酸乙烯聚合物的滴眼剂及其制造方法 |
US5340572A (en) * | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
DE69523044T2 (de) | 1994-03-04 | 2002-06-20 | Univ Washington Seattle | Block- und pfropfcopolymere und dazu gehöriges verfahren |
US5683709A (en) * | 1994-05-05 | 1997-11-04 | Ciba Vision Corporation | Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions |
DE19614823A1 (de) * | 1996-04-15 | 1997-10-16 | Mann Gerhard Chem Pharm Fab | Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge |
MXPA02003731A (es) | 1999-10-15 | 2003-12-11 | Leo Pharm Prod Ltd | Derivados novedosos de acido fusidico. |
DK1654002T4 (da) * | 2003-08-07 | 2014-02-17 | Allergan Inc | Sammensætninger til fremføring af terapeutiske midler til øjnene |
DE102010009475B4 (de) | 2010-02-26 | 2011-11-24 | F. Holzer Gmbh | Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1012060A (en) * | 1964-10-06 | 1977-06-14 | Gilman N. Cyr | Dimethyl sulfoxide gel preparations |
FR2038105A1 (fr) * | 1969-04-01 | 1971-01-08 | Syntex Corp | Composition anti-inflammatoire locale et son mode d'utilisation |
DK135267A (fr) * | 1971-02-25 | |||
DE2239206A1 (de) * | 1971-08-12 | 1973-03-15 | Hydrophilics Int Inc | Copolymer |
US3957740A (en) * | 1972-04-24 | 1976-05-18 | Hydrophilics International, Inc. | Copolymers |
FR2191941A1 (en) * | 1972-07-10 | 1974-02-08 | Serabonian Giacomo | Gelatinising water-sol and aq liqs - by addn of carboxypolymer and alginic acid salt |
DE2265164C3 (de) * | 1972-10-18 | 1985-08-22 | Vsesojuznyj naučno-issledovatel'skij i ispytatel'nyj institut medicinskoj techniki, Moskau/Moskva | Verwendung von Acrylsäureamidcopolymeren zur Herstellung von Grundlagen für ophthalmologische Arzneiformen |
AR206692A1 (es) * | 1972-12-27 | 1976-08-13 | Alza Corp | Agente dispensador de liberacion sostenida de substancias activas |
LU70487A1 (fr) * | 1974-07-08 | 1976-05-31 | ||
US4003991A (en) * | 1974-08-27 | 1977-01-18 | National Patent Development Corporation | Ophthalmic formulation |
JPS5138412A (en) * | 1974-09-24 | 1976-03-31 | Nippon Kayaku Kk | Kokoseizai no seiho |
IL50250A (en) * | 1975-08-27 | 1980-01-31 | Hydrophilics Int Inc | Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups |
JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
-
1978
- 1978-11-23 GB GB7845835A patent/GB2013084B/en not_active Expired
- 1978-12-21 CA CA318,447A patent/CA1108053A/fr not_active Expired
-
1979
- 1979-01-12 FR FR7900789A patent/FR2415459A1/fr active Granted
- 1979-01-16 JP JP54003844A patent/JPS6059885B2/ja not_active Expired
- 1979-01-23 MX MX797677U patent/MX6520E/es unknown
- 1979-01-24 CH CH71879A patent/CH640737A5/de not_active IP Right Cessation
- 1979-01-25 DE DE2902863A patent/DE2902863C2/de not_active Expired - Lifetime
-
1986
- 1986-12-10 JP JP61294588A patent/JPS62215518A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4347238A (en) | 1979-10-26 | 1982-08-31 | Smith & Nephew Associated Companies Limited | Autoclavable emulsion containing silver sulphadiazine |
Also Published As
Publication number | Publication date |
---|---|
FR2415459B1 (fr) | 1983-03-18 |
CA1108053A (fr) | 1981-09-01 |
FR2415459A1 (fr) | 1979-08-24 |
CH640737A5 (de) | 1984-01-31 |
JPS6059885B2 (ja) | 1985-12-27 |
DE2902863C2 (de) | 1994-02-24 |
JPS54110312A (en) | 1979-08-29 |
JPH0428244B2 (fr) | 1992-05-13 |
JPS62215518A (ja) | 1987-09-22 |
DE2902863A1 (de) | 1979-07-26 |
MX6520E (es) | 1985-06-27 |
GB2013084A (en) | 1979-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4295567B1 (en) | Medicament container | |
JPS567714A (en) | Pharmaceutical medicine | |
GB2085732B (en) | Administration set | |
AU513845B2 (en) | Pharmaceutical dosage forms | |
IL58209A0 (en) | Medicament inhaler | |
IL58303A0 (en) | Removable drug implant | |
AU521053B2 (en) | Medicament dosage form | |
JPS55147223A (en) | Pharmaceutical medicine | |
GB2013084B (en) | Ophthalmic drug dosage | |
ZA796549B (en) | New pharmaceutical preparations | |
ZA787000B (en) | Pharmaceutical formulation | |
GB2020655B (en) | Pharmaceutical compounds | |
JPS54157817A (en) | Pharmaceutical prepared solution | |
JPS54132563A (en) | Corticosteroid antiiinflammatry drug | |
ZA793923B (en) | Medicinal formulation | |
JPS54141797A (en) | Therapeutic drug | |
JPS5524175A (en) | Agricultural drug | |
JPS54135795A (en) | Diuretic drug | |
GB2039739B (en) | Medicament against glaucoma | |
JPS5527168A (en) | Drug composition | |
JPS5519257A (en) | Medicine retard form | |
ZA793928B (en) | Medicinal formulation | |
JPS5555114A (en) | Fine drug | |
GB2028660B (en) | Administration set | |
RO77521A2 (fr) | Medicament antirhumatismal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Effective date: 19981122 |